Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine ED90 for Spinal-Induced Hypotension in Cesarean Delivery
NCT00781157Phase 4Completed
- Sponsor
- IWK Health
- Start
- Jan 2008
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of phenylephrine in hypotension, sponsored by IWK Health. Primary endpoint: 90% Effective Dose. Started Jan 2008; status: completed.
02
Drugs
phenylephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT00781157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781157.